蓝丰生化：预计2025年度净利润亏损1.5亿元~2.3亿元

Group 1 - The company, Bluefeng Biochemical, expects a net loss attributable to shareholders of 150 million to 230 million yuan for 2025, with basic earnings per share loss ranging from 0.61 yuan to 0.40 yuan [1] - In the same period last year, the company reported a net loss of approximately 253 million yuan, with basic earnings per share loss of 0.68 yuan [1] - The primary reason for the performance change is a comprehensive review of various assets, leading to asset impairment provisions totaling approximately 64.16 million yuan, which reduced the net profit attributable to shareholders for the current period [1] Group 2 - The agricultural chemical segment continues to incur losses due to a significant increase in raw material prices while the sales prices of main products have been declining [1] - The new energy segment has managed to reduce production costs through technological upgrades, but product prices remain low due to industry competition, resulting in a significant decrease in the loss margin year-on-year, although profitability has not met expectations [1]